The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  66 (2024)
Volume  65 (2023)
Volume  64 (2022)
Volume  63 (2021)
Volume  62 (2020)
Volume  61 (2019)
Volume  60 (2018)
Volume  59 (2017)
Volume  58 (2016)
Volume  57 (2015)
Volume  56 (2014)
Volume  55 (2013)
Volume  54 (2012)
Volume  53 (2011)
Volume  52 (2010)
Related articles

VOLUME 52 , ISSUE 3 ( July-September, 2010 ) > List of Articles

REVIEW ARTICLE

Role of Corticosteroids in the Treatment of Tuberculosis: An Evidence-based Update

Tamilarasu Kadhiravan, Surendran Deepanjali

Keywords : Glucocorticoids, HIV infection, Immune reconstitution inflammatory syndrome, Treatment outcome, Tuberculosis

Citation Information : Kadhiravan T, Deepanjali S. Role of Corticosteroids in the Treatment of Tuberculosis: An Evidence-based Update. Indian J Chest Dis Allied Sci 2010; 52 (3):153-158.

DOI: 10.5005/ijcdas-52-3-153

License: CC BY-NC 4.0

Published Online: 10-06-2022

Copyright Statement:  Copyright © 2010; The Author(s).


Abstract

Corticosteroids are often used as an adjunct in the treatment of various forms of tuberculosis (TB) and for the prevention of complications, such as constrictive pericarditis, hydrocephalus, focal neurological deficits, pleural adhesions, and intestinal strictures. Notwithstanding, they have been proven in clinical trials to improve the following outcomes only — death or disability in human immunodeficiency virus (HIV)-seronegative patients with tubercular meningitis and tubercular pericarditis. Despite a lack of specific evidence for efficacy in HIV co-infected patients with tubercular meningitis or pericarditis, corticosteroids are generally recommended in them as well. Corticosteroids significantly decrease the risk of pleural thickening in patients with tubercular pleural effusion; the clinical significance of this finding, however, is unclear. Recently, it has been demonstrated that use of corticosteroids improve the morbidity in HIV co-infected patients with paradoxical TB immune reconstitution inflammatory syndrome (IRIS). However, evidence favouring the use of corticosteroids in other clinical situations is sparse or lacking. Likewise, the biological mechanisms underlying their beneficial effect in TB meningitis and pericarditis remain poorly understood.

PDF Share
  1. Dooley DP, Carpenter JL, Rademacher S. Adjunctive corticosteroid therapy for tuberculosis: a critical reappraisal of the literature. Clin Infect Dis 1997;25:872-87.
  2. British Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. Br Med J 1948;2:769-82.
  3. Mayo Clinic. Cortisone discovery and the Nobel prize. Available at: http://www.mayoclinic.org/traditionheritage/cortisone-discovery.html. Accessed: April 16, 2010.
  4. The Nobel Foundation. The Nobel prize in physiology or medicine 1950. Available at: http://nobelprize.org/nobel_prizes/medicine/laureates/1950/. Accessed: April 16, 2010.
  5. D'Arcy-Hart P, Rees RJ. Enhancing effect of cortisone on tuberculosis in the mouse. Lancet 1950;2:391-5.
  6. American Trudeau Society. Bull Natl Tuberc Assoc 1951, p4. (Cited in: Capon AW. ACTH, cortisone and tuberculosis. Can Med Assoc J 1952;67:46-8.
  7. Kleinschmidt RF, Johnston JM. Miliary tuberculosis in a cortisone treated patient: case report with autopsy. Ann Intern Med 1951;35:694-702.
  8. King EQ, Johnson JB, Batten GS, Henry WL. Tuberculosis following cortisone therapy: report of a case of rapidly progressive pulmonary tuberculosis following cortisone therapy for rheumatoid arthritis. J Am Med Assoc 1951;147:238-41.
  9. Copp SE, Krzyski TK, Shane SJ. Tuberculous meningitis: combined corticosteroid and antimicrobial therapy. Can Med Assoc J 1956;75:631-4.
  10. Prasad K, Volmink J, Menon GR. Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev 2000;3:CD002244.
  11. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351:1741-51.
  12. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008;1:CD002244.
  13. Afghani B, Lieberman JM. Paradoxical enlargement or development of intracranial tuberculomas during therapy: case report and review. Clin Infect Dis 1994;19:1092-9.
  14. Strang JI, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet 1987;2:1418-22.
  15. Strang JI, Kakaza HH, Gibson DG, Allen BW, Mitchison DA, Evans DJ, et al. Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet 1988;2:759-64.
  16. Hakim J, Ternouth I, Mushangi E, Siziya S, Robertson V, Malin A. Double-blind randomised placebo-controlled trial of adjuvant prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart 2000;84:183-8.
  17. Mayosi BM. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev 2002;4:CD000526.
  18. Strang JI, Nunn AJ, Johnson DA, Casbard A, Gibson DG, Girling DJ. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. QJM 2004;97:525- 35.
  19. Light RW. Tuberculous pleural effusions. In: Pleural Diseases; 3rd edn. Baltimore: Williams & Wilkins; 1995: p.154-66.
  20. Engel ME, Matchaba PT, Volmink J. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev 2007;4:CD001876.
  21. Lee CH, Wang WJ, Lan RS, Tsai YH, Chiang YC. Corticosteroids in the treatment of tuberculous pleurisy: a double-blind, placebo-controlled, randomized study. Chest 1988;94:1256-9.
  22. Bang JS, Kim MS, Kwak SM, Cho CH. Evaluation of steroid therapy in tuberculous pleurisy: a prospective, randomized study. Tuberc Respir Dis 1997;44:52-8.
  23. Galarza I, Canete C, Granados A, Estopa R, Manresa F. Randomised trial of corticosteroids in the treatment of tuberculous pleurisy. Thorax 1995;50:1305-7.
  24. Wyser C, Walzl G, Smedema JP, Swart F, van Schalkwyk EM, van de Wal BW. Corticosteroids in the treatment of tuberculous pleurisy: a double-blind, placebo-controlled, randomized study. Chest 1996;110:333-8.
  25. Elliott AM, Luzze H, Quigley MA, Nakiyingi J, Kyaligonza S, Namujju PB, et al. A randomized, doubleblind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis. J Infect Dis 2004;190:869-78.
  26. Singh MM, Bhargava AN, Jain KP. Tuberculous peritonitis: an evaluation of pathogenetic mechanisms, diagnostic procedures and therapeutic measures. N Engl J Med 1969;281:1091-4.
  27. Sun TN, Yang JY, Zheng LY, Deng WW, Sui ZY. Chemotherapy and its combination with corticosteroids in acute miliary tuberculosis in adolescents and adults: analysis of 55 cases. Chin Med J 1981;94:309-14.
  28. Sharma SK, Mohan A, Banga A, Saha PK, Guntupalli KK. Predictors of development and outcome in patients with acute respiratory distress syndrome due to tuberculosis. Int J Tuberc Lung Dis 2006;10:429-35.
  29. Sharma SK, Tandan SM, Saha PK, Gupta N, Kochupillai N, Misra NK. Reversal of subclinical adrenal insufficiency through antituberculosis treatment in TB patients: a longitudinal follow up. Indian J Med Res 2005;122:127-31.
  30. Smego RA, Ahmed N. A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis. Int J Tuberc Lung Dis 2003;7:208-13.
  31. Tuberculosis Research Centre. Study of chemotherapy regimens of 5 and 7 months’ duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India. Tubercle 1983;64:73-91.
  32. Park IW, Choi BW, Hue SH. Prospective study of corticosteroid as an adjunct in the treatment of endobronchial tuberculosis in adults. Respirology 1997;2:275-81.
  33. Kaplan JE, Benson C, Holmes KH, Brooks JT, Pau A, Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009;58(RR-4):1-207.
  34. Meintjes G, Wilkinson R, Morroni C, Pepper D, Rebe K, Rangaka M, et al. Randomised placebo-controlled trial of prednisone for the TB immune reconstitution inflammatory syndrome [Abstract 34]. In: Proceedings of the 16th Conference on Retroviruses and Opportunistic Infections; 2009 Feb 8-11; Montreal, Canada. Available at: http://retroconference.org/2009/Abstracts/34429.htm. [Accessed May 25, 2010].
  35. Schoeman JF, Elshof JW, Laubscher JA, Janse van Rensburg A, Donald PR. The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Ann Trop Paediatr 2001;21:299- 305.
  36. Simmons CP, Thwaites GE, Quyen NT, Chau TT, Mai PP, Dung NT, et al. The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses. J Immunol 2005;175:579-90.
  37. Thwaites GE, Macmullen-Price J, Tran TH, Pham PM, Nguyen TD, Simmons CP, et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: an observational study. Lancet Neurol 2007;6:230-6.
  38. Green JA, Tran CT, Farrar JJ, Nguyen MT, Nguyen PH, Dinh SX, et al. Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis. PLoS One 2009;4:e7277.
  39. van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, et al. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis. Pediatr Infect Dis J 2004;23:608-13.
  40. van de Beek D. Brain teasing effect of dexamethasone. Lancet Neurol 2007;6:203-4.
  41. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J Infect 2009;59:167-87.
  42. Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603-62.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.